Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so. Trading at $852 per share (as I write), LLY stock would need to hit approximately $1,055 per share, a 24% increase, to achieve this milestone.
Because of its dominance in the $150 billion GLP-1 weight-loss and diabetes market, robust financial performance, and innovative pipeline, this ambitious goal is readily attainable, despite competitive and regulatory challenges.
This post appeared first on 24/7 Wall St.